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Research in adults and older children has shown an association between 
Mycobacterium tuberculosis and helminth infection, with those infected with 
helminths at greater risk of tuberculosis. This association is believed to be on 
the basis that chronic helminth infection can result in a functional impairment 
of the immune response that is necessary to clear or control infection by 
Mycobacterium tuberculosis (Elias et al. 2001; Rook et al. 2006; Fincham 
2001). 
 
It is thus possible that the introduction of regular deworming programmes in a 
vulnerable population of children under the age of five years could assist their 
immune systems to ward off tuberculosis infection and reduce the risk of 
tuberculosis disease in such a population. 
 
A randomised controlled trial to compare two methods of administering bacille 
Camlette-Guerin (BCG) vaccination to newborns from a high tuberculosis risk 




The objective of this study is to determine if young children in a high-risk 
tuberculosis population who have been vaccinated with BCG at birth and have 
been treated for helminth infection are at lower risk of tuberculosis disease 
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Method  
 
A case control study nested within a cohort recruited for a separate 
randomised control trial to compare two methods of administering BCG 
vaccination was carried out. Children who presented to their local clinic or 
hospital with symptoms of tuberculosis or a history of exposure to tuberculosis 
were admitted to a case verification (CV) ward for investigation of tuberculosis. 
 
Investigation of tuberculosis included a detailed history, including past helminth 
treatment, physical examination, tuberculin skin test, chest radiograph, gastric 
washing and induced sputum for culture of tuberculosis and clinical 
examination. A diagnostic algorithm was developed by specialist physicians and 
biostatisticians to classify the children into one of five tuberculosis categories. 
 
A total of 510 children (median age 18.13 months) were included in the 
primary analysis of this case control study. Those defined as cases were the 
328 classified as “definite or probable TB” and 182, classified as “not TB”, 
comprised the control group. Those classified as "possible TB" or "unlikely TB" 
were excluded. 
 
A secondary analysis was performed that included the 337 children who had 
been classified as “unlikely TB” with the controls resulting in a total of 847 
children (median age 18.37 months). The 328 children classified as “definite or 
probable TB” were defined as cases and the 519 classified as “unlikely or not 
TB” comprised the control group. 
 
Univariate analysis was used to explore a possible relationship between 
tuberculosis and helminth treatment using all the variables in the sub-study 
(n=510 primary analysis; n=847 secondary analysis). For both the primary and 
secondary analysis a multivariate logistic regression model was built using a 
reduced sample that had a complete set of data for all the variables: primary 
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on a more complete sample as the final variables selected had fewer missing 





A total of 35.69% of the study sample in the primary analysis had been treated 
for helminth infection. The proportion of children who had been treated for 
helminth infection was similar in the cases and controls (35.98% and 35.16% 
respectively). Univariate logistic regression showed no association between 
tuberculosis and treatment for helminth infection: [odds ratio (OR) 1.04; 95% 
confidence interval (CI) 0.71 - 1.51]. 
 
Multivariate analysis adjusted for the effect of nutritional status, recorded as 
height for age z score (haz), number of occupants sharing the same dwelling 
as the child, gender and birth site showed a similar result: (OR 1.03; 95% CI 
0.69 – 1.53). The OR is very close to 1 with a 95% CI that includes 1, which 
indicates that there is not a statistically significant association between 
tuberculosis and helminth treatment. 
 
In the secondary analysis, a total of 38.61% of the study sample had been 
treated for helminth infection. In this analysis the proportion of children who 
had been treated for helminth infection showed a difference between the cases 
and controls (35.98% and 40.27% respectively). Univariate logistic regression 
showed a 17% relative reduction in tuberculosis odds but this was not a 
statistically significant result: (OR 0.83; 95% CI 0.63 – 1.11). Multivariate 
analysis adjusted for the effect of haz, number of children sharing the same 
dwelling as the child and gender, showed a similar result: (OR 0.85; 95% CI 
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Conclusion 
 
The primary analysis of this observational study does not support the 
hypothesis that helminth treatment reduces the risk of tuberculosis disease in 
young children in a high-risk tuberculosis population. Although the secondary 
analysis showed a 15% relative reduction in tuberculosis odds after adjusting 
for the effect of haz, number of occupants sharing the same dwelling as the 




This study does not support the hypothesis that helminth treatment reduces 
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1. INTRODUCTION 
 
Mycobacterium tuberculosis is the agent that causes tuberculosis, a disease 
that is estimated to infect about one third of the world’s population (WHO, 
2005). 29% of the global burden of tuberculosis is in sub-Saharan Africa where 
the incidence rate of smear positive tuberculosis in 2005 was 350 cases per 
100 000 population (WHO, 2005). 
 
Childhood tuberculosis contributes significantly to the global burden of this 
disease, with about one million children developing tuberculosis annually 
worldwide, which accounts for about 11% of all cases of tuberculosis (Marais 
et al. 2006; Fincham, 2001). 
 
Childhood tuberculosis differs from adult tuberculosis by the way in which the 
immune system responds. Children under five years of age are more likely than 
adults to develop tuberculosis disease following infection and the time from 
infection to disease is likely to be shorter in children than in adults (Walls et al. 
2004). This will have implications for the prevention of progression from 
infection to tuberculosis disease (Marais et al. 2006; Fincham, 2001). 
 
Tuberculosis is contagious and spreads through the air. When a person with 
active pulmonary tuberculosis coughs, Mycobacterium tuberculosis is spread 
into the immediate environment in microdroplets which can remain in the air 
for prolonged periods. People in contact with an active case of pulmonary 
tuberculosis may inhale these micro droplets containing Mycobacterium 
tuberculosis (Elias et al. 2006; Grosset, 2003; Campbell et al. 2006). After 
infection with tuberculosis the infected person mounts a response to the 
pathogen which is so effective that on average 90% of humans with an 
immunocompetent system are able to control or clear the infection and avoid 
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The variation in the ability of the human body to handle tuberculosis has been 
explored (Elias et al. 2001). Various suggestions regarding the difference in 
protection against tuberculosis disease have included exposure to 
environmental mycobacteria (atypical mycobacteria), nutritional differences, 
genetic or physiological differences and perturbation of the immune system by 
chronic infectious diseases including helminth infection. 
 
Specifically, chronic helminth infection can result in functional impairment of 
the immune response that is necessary to clear or control infection by 
Mycobacterium tuberculosis. Protection against tuberculosis is associated with 
a predominant T helper lymphocyte Type 1 (Th1) cell mediated immune 
response to mycobacterial antigens, characterised by interferon-gamma 
release, while susceptibility to tuberculosis is associated with a reduced Th1 
response. Helminth infection results in a depressed Th1 cell mediated 
response, and Th2 polarisation, with or without an elevated T regulatory 
lymphocyte (Treg) response, which results in a reduction of interferon-gamma 
production necessary for protection against Mycobacterium tuberculosis (Elias 
et al. 2001; Rook et al. 2006; Fincham 2001). 
 
Helminth infection could thus have a marked effect on the human response to 
Mycobacterium tuberculosis and facilitate the spread of this disease (Bundy et 
al. 2000; Elliot et al. 2007; The Lancet Editorial, 2004). 
 
Communities with a high prevalence of helminth infection are often those 
where the incidence of tuberculosis is high – typically those where the living 
conditions are poor and where over-crowding, poverty and malnutrition are 
common (Elias el al. 2001; Campbell et al. 2006). It is estimated that more 
than two billion people worldwide have helminth infections. In endemic areas, 
children could be infected as soon as they are able to crawl. (Elias et al. 2001). 
In a study conducted in the Eastern Cape and KwaZulu-Natal, about 20% of 
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There is convincing evidence that helminth control in the Western Cape is 
neglected (Bentwitch et al. 1999). Established benefits of community control of 
helminth infection include enhancing development in children, reduction in 
anaemia and reduction in malnutrition (Alderman et al. 2006). 
 
In addition to enhancing the nutritional status, growth and intellectual 
development of children (WHO, 2005), there is accumulating evidence that 
prevention of helminthiasis by mass deworming could improve the immune 
response to tuberculosis infection and thus potentially decrease susceptibility to 
tuberculosis and slow progression to disease once infected (Adams et al. 2005; 
Marais et al. 2006; Fincham, 2001; Bundy et al. 2000; The Lancet Editorial, 
2004). 
 
It is thus possible that introduction of regular, six-monthly deworming of 
children under the age of five years and the inclusion of mass deworming in 
immunisation campaigns could result in a reduction of helminth infections in 
this age group, and result further in a reduction in tuberculosis disease. 
 
Between 26th March 2001 and 31st
 
 July 2006, a randomised controlled trial was 
conducted by the South African Tuberculosis Vaccine Initiative which compared 
two methods of BCG vaccination administration in preventing tuberculosis in 
very young children. 
The primary objective of the trial was to compare the efficacy of the 
percutaneous to that of the intradermal route of administering BCG in 
preventing tuberculosis during the first two years of life. The primary endpoint 
of the trial was the incidence rate of tuberculosis during the first two years of 
life. 
 
The study was based in the Boland Overberg region of the Western Cape in the 
Republic of South Africa, centred at Worcester, where the burden of 
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was 602/100 000 in 2004 (Nicol et al. 2008). The population has a relatively 
low HIV sero-prevalence for South Africa: between 5.7 and 6.2% of pregnant 
women attending public health service antenatal clinics are HIV sero-positive 
(Hawkridge et al. 2008). The estimated incidence rate of tuberculosis disease 
in children aged younger than five years is about 2 500/100 000 per annum, 
which is very high (Hawkridge et al. 2008). 
 
In addition to the trial collecting information on tuberculosis, demographics and 
socio-economic status, information was collected on previous helminth 
treatment. This study thus provided an opportunity to test the hypothesis that 
helminth treatment reduces the risk of tuberculosis disease in young children 




It is important to establish whether children who are treated for helminth 
infection are protected against tuberculosis. 
 
As tuberculosis is a common disease, a reduction in tuberculosis cases due to 
introduction of mass deworming programmes in children younger than five 
years of age could significantly decrease the burden of tuberculosis disease in 
this age group. This would be strong motivation to introduce regular 
deworming programmes to include preschool children and include mass 




The objective is to determine the association between past helminth treatment 
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1.3 Study hypothesis 
 
In a high-risk tuberculosis population, young children who have been 
vaccinated with BCG at birth and have been treated for helminth infection will 
have lower odds of tuberculosis disease than children who have been 
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2. LITERATURE REVIEW 
 
2.1 Objective of literature review 
 
The objective of this literature review was to assess existing evidence of the 
effect of chronic helminth infection on the immune system, as well as evidence 
of a possible association between tuberculosis and helminth infection or 
helminth treatment, to critically appraise this evidence and to summarise the 
outcomes of this research. 
 
2.2 Search strategy 
 
Using the key words “helminth infection” or “worm infestation” or “helminth 
treatment” and “tuberculosis” or "TB", the following resources were searched 
to identify existing evidence of an association between helminth infection and 
tuberculosis: 




In addition, specialist journals on infectious disease were scanned manually 
and physicians were asked for guidance by means of personal communication. 
 
2.3 Summary of relevant research 
 
Helminth infections are common in large parts of the world and it is estimated 
that more than a quarter of the world’s population are infected. This burden is 
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America where the burden of other infectious diseases, including tuberculosis, 
is also high (Borkow et al. 2000; Bundy et al. 2000). 
 
During a period of 15 years, about 60 000 Ethiopians emigrated from Ethiopia 
to Israel. More than 80% of these immigrants were infected with a least one 
helminthic parasite. 
 
The immigration of these Ethiopians allowed researchers the opportunity to 
investigate the effect of chronic immune activation caused by helminth 
infection on immune responses and the ability of the immune system to cope 
with infections (Borkow et al. 2000).  
 
Three groups were identified and included in the study. The first group 
comprised recently immigrated Ethiopians with helminth infection, before 
deworming. The second group comprised Ethiopians that had been living in 
Israel for at least three years, had been treated for helminth infection and were 
at the time of the study free of helminth infection. The third group comprised 
healthy Israeli-born helminth free individuals. The immune profiles of the three 
groups were analysed and compared (Borkow et al. 2000). 
 
The study showed a clear dysregulation of several immune parameters in those 
Ethiopians recently immigrated to Israel compared to the group that had been 
born in Israel. The differences between the group who had immigrated to 
Israel at least three years before the study and the group who had been born 
in Israel were not as great, suggesting that the immune profiles of the 
Ethiopians gradually returned to normal after immigration to Israel (Borkow et 
al. 2000).  
 
The researchers concluded that although the improvement in health care and 
nutrition would have contributed to an improvement in the immune system, 
eradication of helminth infection was the most important factor in this 
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The health benefits of deworming preschool children have been studied in 
eastern Uganda. A randomised controlled trial was used to investigate the 
effect of including an anthelmintic in a new health programme for children. The 
study population was cluster randomised by parish. 
 
Out of the 48 parishes included in the new health programme, 24 parishes 
offered children aged between one and seven years anthelmintic treatment in 
addition to standard services on child health days, over a three-year period 
(Alderman et al. 2006).  
 
The main outcome of the study was weight gain. The results of the study 
showed about a 10% increase in weight gain in children from the parishes that 
had been randomised to offer an additional anthelmintic treatment to standard 
services: [166 g per child per year; (95% CI 16–316)] above expected weight 
gain when anthelminic treatment was given bi-annually. The weight gain was 
5% if the treatment was given annually (Alderman et al. 2006).  
 
The researchers concluded that regular deworming of preschool children, as 
part of regularly scheduled health services, was practical and resulted in weight 
gain (Alderman et al. 2006). 
 
The question has been raised in the research community of additional health 
benefits of deworming young children including possible protection against 
tuberculosis disease (Bundy et al. 2000; Tristao-Sa et al. 2002; Elias et al. 
2006). 
 
Available epidemiological data regarding associations between helminth 
infection and tuberculosis are largely observational. Two previous studies have 
shown a significantly higher prevalence of helminth infection in patients with 
pulmonary tuberculosis compared to control groups as shown in Table 1 
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Potential confounders  








- nutritional status 
- HIV status 
OR 5.19 
(2.33 – 11.69) 
Elias 
(2006) 





 OR 4.2 (2.7 – 8.7) 
 
Between 1997 and 1999, researchers conducted a case control study in 
hospitalised patients in Brazil. Stool samples were examined for intestinal 
nematodes in 57 cases of pulmonary tuberculosis and 86 randomly selected 
stool examinations from patients with other diseases. The control group 
individuals were matched to the cases by age, gender and location. The results 
showed that prevalence of helminths was five times higher in the patients with 
pulmonary tuberculosis than in the control group: (OR 5.19; 95% CI 2.33 - 
11.69) (Tristao-Sa et al. 2002). Although the cases and controls were matched 
by age, gender and neighbourhood, these results could have been confounded 
by HIV status which was not evident in the article. As the patients were from 
the same community it is unlikely that socio-economic status was a 
confounder. 
 
This result was confirmed in a study done by Elias between October 1999 and 
2002 in Ethiopia, where both tuberculosis and helminth infections are endemic 
(Elias et al. 2006). The study design was case control: 230 cases with clinical 
features of tuberculosis and smear positive sputum were compared to 510 
controls who were selected from the same household as the case, had been 
resident in the same house for at least 12 months and were found to be free of 
any signs and symptoms of tuberculosis on normal physical examination. 
 
The researchers found a strong association (OR 4.2; 95% CI 2.7 – 5.9) 
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helminth infection together with HIV infection, poverty and poor living 
conditions may be an important risk factor for tuberculosis (Elias et al. 2006). 
Age, gender and HIV status were treated as potential confounding variables. 
The researchers adjusted for their possible effect by including them in the 
logistic regression model. As the controls were selected from the same 
household, it is unlikely that confounding by nutritional status would have 
influenced these results. 
 
These results support the hypothesis that the immune perturbation induced by 
helminth infection may lessen the host’s response to Mycobacterium 
tuberculosis, thus facilitating infection and progression to tuberculosis disease. 
If this hypothesis holds, eradication of helminth infections could have a 
significant impact on control of tuberculosis in the developing world (Tristao-Sa 
et al. 2002; Bentwich et al. 1999). 
 
However, although the studies mentioned above found strong associations 
between helminth infection and tuberculosis disease in adults and older 
children (age range 11 to 79 years), with ORs of 5.19 and 4.2 respectively, 
little is know about the effect of helminth treatment on the incidence of 
tuberculosis disease in children or adults. 
 
The first trial to examine the effects of helminths and deworming on 
tuberculosis among young children is currently being conducted in Uganda. 
The study is a randomised controlled trial which will allow the role of helminths 
and the benefits of deworming to be determined in relation to infectious 
diseases including tuberculosis, and the effect on anaemia, growth and 
intellectual development is to be assessed. The trial has three randomised, 
double blinded, placebo controlled interventions. Pregnant mothers are 
randomised to receive either albendazole or placebo and praziquantel or 
placebo. At the age of 15 months their children are randomised to receive 
either albendazole or placebo given every three months; to continue until the 
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In the absence of results from randomised trials, observational data may help 
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3.  METHODS 
 
This study was conducted in the Boland Overberg region located in the 
Western Cape Province of South Africa, in the municipal districts of Breede 
River Winelands, Breede Valley and Witzenberg. The economy is based on 
agriculture and tourism resulting in the population being small and dispersed. 
The regional centre is the town of Worcester. 
 
3.1 Study design 
 
A case control study nested within a cohort recruited for a separate 
randomised control trial to compare two methods of administering BCG 
vaccination as described earlier was carried out. 
 
3.2 Study site and study population  
 
The study was carried out in a high tuberculosis burden population. The smear 
positive detection rate of tuberculosis in this area was 602/100 000 in 2004 
(Nicol et al. 2008). The population has a relatively low HIV sero-prevalence for 
South Africa: between 5.7 and 6.2% of pregnant women attending public 
health service antenatal clinics (Hawkridge et al. 2008). The estimated 
incidence rate of tuberculosis disease in children aged less than five years is 
about 2 500/100 000 per annum, which is very high (Hawkridge et al. 2008). 
 
The comparison of the two methods of administering BCG was needed as the 
intradermal method of administration of BCG is almost universally accepted 
over percutaneous administration without direct evidence from a clinical trial. 
The reasoning behind this was that although it was easier to administer 
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In 1999 the South African Department of Health decided to fall in line with 
World Health Organization (WHO) recommendations to change the method of 
BCG vaccination from percutaneous to intradermal. However, it was the view 
that additional research on the methods of administering BCG vaccination 
should be carried out. This trial provided the opportunity to carry out the sub-
study described in this dissertation. 
 













  23 
3.3 Sample size and randomisation of the cohort study 
 
The study cohort comprised 11 680 neonates, vaccinated with BCG within 24 
hours of birth, whose mother had signed informed consent and were enrolled 
in the study. Children excluded were those who were not eligible to receive 
routine BCG vaccination within 24 hours of birth, were not from the study area 
or were not born at one of five public maternity health units. 
 
The randomisation sequence was generated by the study statistician in 
Microsoft Excel. The randomisation was by week and balanced in eight-week 
blocks of four intradermal and four percutaneous in one eight-week cycle. 
 
The children were enrolled by midwives and study counsellors who were aware 
of the week's vaccine allocation. Allocation concealment and masking did not 
take place. 
 
3.4 Surveillance for tuberculosis and referral to the case 
verification ward 
 
The cohort was followed up for at least two years after BCG vaccination. Active 
surveillance for tuberculosis disease was used for the first three months. A total 
of 4 851 children were screened for incident illness that could have been 
tuberculosis when they attended a local health facility for routine vaccination 
visits at six, 10 and 14 weeks of age. Any children with a history of exposure to 
tuberculosis or those who presented with symptoms suggestive of tuberculosis 
were admitted to a specialised tuberculosis case verification ward at 
Brewelskloof Hospital, Worcester. Passive surveillance was based on scanning 
hospital admission lists, tuberculosis registers and mortality records for illness 
suggestive of tuberculosis or death. All surveillance events that were reported 
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The following symptoms were considered suggestive of tuberculosis: cough, 
fever, night sweats, loss of weight for two weeks or more, or any episode of 
haemoptysis. 
 
3.5 Investigation of tuberculosis 
 
A ward at the regional tuberculosis referral hospital in Worcester was equipped 
to carry out procedures required for the diagnosis of tuberculosis in children. 
Investigation for tuberculosis included a detailed history, physical examination, 
tuberculin skin test, chest radiograph and culture of sputum obtained through 
early morning induced sputum and gastric lavage. All mothers were asked to 
consent to an HIV rapid test if the child was younger than 18 months and HIV 
polymerase chain reaction if the child was older than 18 months. Both Mantoux 
and Tine tuberculin skin tests were administered. A Mantoux reaction of 
greater than or equal to 15 mm was considered positive in HIV negative 
children and a Mantoux reaction of greater than or equal to 4 mm was 
considered positive in HIV positive children. A Tine reaction of greater than 
grade 2 was considered positive in all children. 
 
A panel of three expert chest x-ray reviewers classified the chest radiograph 
into one of five TB classifications: “Highly likely TB”, “likely TB”, “suspicious of 
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3.6 Tuberculosis diagnostic algorithm and choice of cases 
and controls 
 
A TB diagnostic algorithm was developed by specialist physicians and 
biostatisticians to classify the study population into one of five tuberculosis 
categories: definite TB, probable TB, possible TB, unlikely TB and not TB 
(Table 2) (Hawkridge et al. 2008). 
 
Table 2: Definition of tuberculosis classification 
TB Classification Defined as  
Definite  microbiological confirmation of Mycobacterium tuberculosis.  
Probable chest radiograph compatible with TB  
at least one additional feature of TB1
Possible 
. 




chest radiograph not suggestive of TB and diagnosed as TB by 
the treating physician; 
or 
chest radiograph not suggestive of TB and two or more 
additional features.  
Unlikely negative sputum microbiology, 
chest radiograph not suggestive of TB, 
at least one additional feature of TB1
or 
; 
diagnosed as TB by the treating physician without any other 
criteria being met. 
Not negative sputum microbiology,  
chest radiograph not suggestive of TB, 
no additional features of TB1, 
not diagnosed as TB by the treating physician. 
1 
cough for at least two weeks 
Additional features: 
failure to thrive 
recent loss of weight 
smear positive for acid fast bacilli (AFB) 
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For the purpose of this case control study two types of control group were 
defined. For the primary analysis, those admitted to the hospital for 
investigation and classified as definite or probable TB were defined as cases, 
and those classified as not TB comprised the control group. 
 
In the secondary analysis, those classified as unlikely TB were included in the 
control group. 
 
The two-year follow up of the 11 680 study subjects ended in 2006. In this 
period 1 445 children had been admitted to the case verification ward for 
investigation of tuberculosis. Some of the children were admitted more than 
once, resulting in 1 867 admissions to the case verification ward. 
 
Table 3: Summary of admissions to the case verification ward by 
tuberculosis classification. 
 (n=1 867) 
TB Classification n (%) 
Definite TB 193 (10.3) 
Probable TB 280 (15.0) 
Possible TB 438 (23.5) 
Unlikely TB 599 (32.1) 
Not TB 357 (19.1) 
 
At each admission to the case verification ward a full tuberculosis evaluation 
was performed. For this study only one admission per child was used in the 
analysis. A total of 11 children who were analysed in this case control study 
were admitted to the CV ward more than once. In this instance, the admission 
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Table 4: Selection of admission 
TB classification Admission selected 
If both of the admissions were classified 
as definite or probable TB 
The first admission was used in the 
analysis 
If both of the admissions were classified 
as not or unlikely TB  
The first admission was used in this 
analysis 
If one admission resulted in a definite or 
probable TB classification and the other 
an unlikely or not TB classification 
The admission classified as definite or 
probable was used in this analysis 
 
Figure 2 summarises the cohort enrolled for the trial, the number of children 
assessed for possible tuberculosis, the exclusion criteria for this case control 
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3.7 Exclusions 
 
The following tuberculosis investigations were excluded from this analysis: 
 
• 117 tuberculosis cases diagnosed outside the case verification ward. 
These children had been diagnosed as tuberculosis cases and started on 
tuberculosis treatment by the public health service before the study staff 
were able to admit them to the case verification ward for investigation 
of tuberculosis. These children were not included in this analysis as the 
diagnosis of tuberculosis had not been made using the diagnostic 
algorithm, it was also not known if any of the children had been treated 
for helminth infection. 
• 135 tuberculosis cases diagnosed as definite or probable tuberculosis in 
the first nine months after birth. These children were diagnosed before 
they had much chance of helminth treatment.  
• 501 tuberculosis investigations in children younger than 9 months. Very 
few children were treated for helminth infestation before the age of nine 
months. 
• 25 whose parents/guardians had no response to the question “was your 
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A summary of the remaining 1 206 tuberculosis investigations are shown in 
Table 5.  
 
Table 5: Summary of tuberculosis classification after general 
exclusions (n = 1 206) 
TB Classification n (%) 
Definite TB 106 (8.8) 
Probable TB 224 (18.6) 
Possible TB 317 (26.3) 
Unlikely TB 368 (30.5) 
Not TB 191 (15.8) 
Total 1 206 (100.0) 
 
Of the 330 cases (106 definite TB, 224 probable TB), two children had been 
admitted twice, leaving 328 cases for this analysis. Of the 191 controls (not TB) 
for the primary analysis, 9 children had been admitted twice, leaving 182 
controls for this analysis. 
 
In the secondary analysis, of the additional controls from those classified as 
unlikely TB (368), 31 children had been admitted twice, leaving 337 unlikely 
TB. The total control group for the secondary analysis was thus 519. 
 
The 317 children who were classified as possible TB were not used in this 
analysis on the grounds that the children in this group were not suitable for a 
case diagnosis of tuberculosis but could not be used as controls as they had 
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Table 6: Final case and control selection 
 (primary analysis) 
TB Classification Number Allocation 
Definite TB 106 case 
Probable TB 222 case 
Not TB 182 control 
 
The final data set for the primary analysis included 328 cases and 182 controls 
as shown in Table 6. 
 
Table 7: Final case and control selection 
 (secondary analysis) 
TB Classification Number Allocation 
Definite TB 106 case 
Probable TB 222 case 
Unlikely TB 337 control 
Not TB 182 control 
 
The final data set for the secondary analysis included 328 cases and 519 
controls as shown in Table 7. 
 
The secondary analysis was performed to establish if the result of the primary 
analysis held true when those classified as “unlikely TB” were included in the 
control group as well as to increase the power of the study.  
As one of the reasons that a child might have been treated for helminth 
infection by the public health service was for loss of weight or failure to thrive 
unrelated to tuberculosis, and these symptoms had been excluded by the TB 
diagnostic algorithm in the “not TB” group, it was decided to include this group 
to determine if the result of the primary analysis was different given that more 
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3.8 Power of the study 
 
The power of the study was calculated to detect differential proportions treated for helminth infection among cases and 
controls as shown in Tables 8 and 9 given the fixed sample size. 
 
Table 8: Estimated power of the study 
 (primary analysis)  
Proportion of cases treated for 
helminth infection 
Proportion of controls treated 
for helminth infection 
OR 95% CI Power 
15% 25% 0.53 0.34 - 0.84 74% 
18% 30% 0.52 0.34 – 0.79 84% 
25% 40% 0.51 0.35 – 0.75 92% 
 
Given these assumed proportions of cases and controls treated for helminth infection, and given 328 cases and 182 controls, 
the primary analysis was powered in excess of 70% to prove a 50% relative difference statistically significant at the 5% level, 
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Table 9: Estimated power of the study  
(secondary analysis) 
Proportion of cases treated for 
helminth infection 
Proportion of controls treated 
for helminth infection 
OR 95% CI Power 
15% 25% 0.49 0.34 - 0.71 93% 
18% 30% 0.52 0.36 – 0.73 97% 
25% 40% 0.50 0.37 – 0.69 99% 
 
By including those classified as “unlikely TB” in the control group, the power of the study was increased to greater than 90% 
to prove a 50% relative difference statistically significant at the 5% level, between helminth treatment and tuberculosis given 
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3.9 Measurement  
 
3.9.1 Demographic patient data 
 
The following data were recorded at enrolment and analysed in this case 
control study: child’s date of birth, gender, birth weight, birth length, 
gestational age, birth site, mother’s date of birth and ethnicity. 
 
3.9.2 Tuberculosis investigation data 
 
The following data were recorded at the time of admission to the case 
verification ward and analysed in this case control study: date of admission, 
number of referrals to the case verification ward, height at admission, type of 
housing (formal or informal), type of community (urban or farm), number of 
occupants sharing the same dwelling as the child and previous treatment for a 
helminth infection. 
 
3.9.3 Tuberculosis diagnostic algorithm data  
 
The following data were recorded at admission to the case verification ward 
and programmed by the diagnostic algorithm to classify each admission into 
one of five tuberculosis categories: smear and culture sputum microscopy, 
chest radiograph, Mantoux and Tine tuberculin skin test, clinical symptoms of 
cough for more than two weeks, failure to thrive, recent loss of weight, HIV 
status and a diagnosis of tuberculosis by the treating physician. 
 
The variables that have been used for this analysis, the codes ascribed and the 
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Table 10: Variables extracted from the database of the main study.  
Variable name Comment 
Mother’s age (years) Mother’s age at birth calculated as [Child’sDateOfbirth]- 
[Mother’sDateOfbirth] 
Child’s age at admission 
(months)  
Age at admission calculated as [DateOfAdmission]-
[DateOfBirth] 
Gender Gender coded as: male=1; female = 0 
Ethnicity coded as: black = 1; coloured = 2; asian = 3; white = 4 
Birth weight (kg)  
Low birth weight A birth weight <2.5 kg coded as low birth weight 
Gestation (weeks) Gestation <37 weeks coded as an early birth 
Type of community Farm or urban 
Type of housing Formal or informal 
Number of people living in the 
same house 
A measure of socio-economic status 
Birth site Birth sites coded as: Worcester = 1; Ceres = 2; 
Robertson = 3; Montagu = 4 
TB diagnosis Coded as: Definite/probable TB = 1; not TB = 0 
For the secondary analysis, unlikely TB = 0,not TB=0 
Treatment for helminth infection Coded as: yes = 1; no = 0 
Height (cm) Height in cm at admission was used to calculate the 
height for age z score 
HIV status Coded as: positive = 1; negative = 0 
 
A random 10% quality check was completed on the data. If the child had been 
treated for helminth infection by the local health service this treatment would 
have been recorded on the Road to Health Card (RTHC). The RTHC is issued to 
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doctors to monitor the child’s development in the first five years of life. It is 
also used to record immunisations and additional treatments including helminth 
treatment. The RTHC was also used as an additional source of data if data 
were missing from the study case report form (CRF). Data that were not 
recorded or measurements that were not taken are summarised in Tables 11 
and 12. 
 
Table 11: Missing variables by group 
Variable Total Case Control 
Ethnicity 22 11 (3.4%) 11 (6.0%) 
Mother’s date of birth 12 7 (2.1%) 5 (2.7%) 
HIV status 29 21 (6.4%) 8 (4.4%) 
haz 8 5 (1.5%) 3 (1.6%) 
Number of occupants 9 2 (0.6%) 7 (3.8%) 
 
Table 12: Missing variables by helminth treatment 
Variable Total Helminth treatment 
(Rx) 
No helminth Rx 
Ethnicity 22 6 (3.3%) 16 (4.9%) 
Mother’s date of birth 12 3 (1.6%) 9 (2.7%) 
HIV status 29 15 (8.2%) 14 (4.3%) 
haz 8 1 (0.5%) 7 (2.1%) 
Number of occupants 9 4 (2.2%) 5 (1.5%) 
 
The missing variables appear to be randomly scattered thoughout the data-set 
which will reduce any bias that could be introduced by reducing the sample to 
include only variables that do not have missing values in the model selection 
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3.10 Ethical considerations 
 
Written, informed consent was obtained from parents or guardians of all study 
participants at initial trial enrolment such that they understood that the child 
would receive standard BCG vaccination administered either percutaneously or 
intradermally. The parent or guardian was informed that if the child suffered 
any effects as a direct result of the BCG vaccination, medical care would be 
provided by the public health services. No other compensation was offered.  
 
Written, informed consent was obtained from the parents or guardians of all 
study participants who were admitted to the case verification ward for 
investigation of tuberculosis. This consent included information on HIV and 
permission to take blood for an HIV test. Counselling was offered before and 
after HIV testing. On discharge the parents or guardians were compensated 
with a small hamper of baby products or a small toy to the value of R50.00. 
 
The study was approved by the Research Ethics Committee of the University of 
Cape Town. (REC Ref 271/2000). 
 
3.11 Statistical analysis 
 
The data were analysed using STATA 8 statistical software (STATA 
Corporation, College Station, TX USA) and EpiInfo version 6 [Database and 
statistical software for public health professionals, Centres for Disease Control 
and Prevention (CDC)]. 
 
Exploratory data analysis of categorical and continuous variables included 
frequency tables, and histograms of continuous variables to determine 
distribution. Normally distributed continuous data were summarised by mean 
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interquartile range. Categorical data were summarised as proportions with 95% 
CIs. 
 
Nutritional status of the children was calculated as height for age z score (haz) 
using date of birth, date of measurement, gender and height at admission. The 
haz score was calculated using the CDC/WHO 1998 reference (WHO, 1997). 
Height for age z score (haz) is a tool that can be used to assess a child’s 
growth and general nutritional status using a standardised age and gender 
specific growth reference. The z score is expressed as standard deviations 
above or below the reference mean. The reference has an expected mean z 
score of 0 and a standard deviation of 1.0 (WHO, 2007). A haz below -2 
describes stunting, which implies long term malnutrition and poor health 
(WHO, 2007). 
 
Univariate and multivariate logistic regression analysis were used to explore the 
association between helminth treatment and tuberculosis. 
 
Potential confounding variables are variables that are related to the outcome, 
which in this study is tuberculosis disease, among those not exposed to 
helminth treatment and, in addition, are related to the exposure variable, 
which in this study is helminth treatment. 
 
All co-variables were first tested for potential confounding using the following 
method: 
Univariate analysis was used to investigate: 
1. the relationship of potential confounders with tuberculosis disease 
amongst the subset of children not treated for helminth infection;  
and 
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If variables were found to be associated with both these outcomes, they were 
considered potential confounders and added to the model that just contained 
helminth treatment to investigate the association between helminth treatment 
and tuberculosis disease after adjustment for potential confounding variables. 
 
Each co-variable was added separately to the best model of confounders – 
nested models were compared using the likelihood ratio chi-square statistic 
(lrtest) and both nested and non-nested models were compared using the 
Akaike’s information criterion (AIC). Model building continued until adding co-
variables did not improve the model.  
 
Model checking procedures were accomplished by calculating residuals. A plot 
of standardised Pearson residuals versus the linear component of the model 
was used to check both the functional form of the model and to identify 
outlying observations. 
 
Dummy variables were created for birth sites Ceres, Robertson and Montagu, 
using the birth site of Worcester as the reference category. 
 
The secondary analysis was performed as above on the data that included 
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4. RESULTS 
 
4.1 Quality of information 
 
The data quality was believed to be of a high standard as the study population 
were admitted to the case verification ward where trained clinical research 
nurses took a detailed history and performed the necessary tests. 
 
To validate the accuracy of previous treatment for helminth infection, a 10% 
sample of CRFs were compared to the child’s Road to Health Card (RTHC) 
where a record of helminth treatment was recorded by staff at the local health 
facility. No discrepancies in the 10% sample check that was discussed in the 
measurement section, between the data recorded on the CRF and the RTHC, 
were found. It is possible that the interviewer used the RTHC as a source of 
previous helminth treatment in addition to the mother’s recall. 
 
4.2 Baseline characteristics of the study population  
 
The baseline analysis included 510 children as shown in Table 13. 
 
The mean age of the mother at the child’s birth was 25.71 years (range: 14.18 
– 43.64). 48 (9.4%) of the mothers were younger than 18 years at the child’s 
birth. 
 
23.53% of the mother’s reported that they lived on a farm and the number of 
people sharing the same dwelling with the child had a median of 5 (range: 1 - 
20). 
 
9.41% reported that they were living in informal housing, which included any 
type of shack (zinc, wood or iron) or “wendy house” that was free standing and 
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The median gestational age at the child’s birth was 39 weeks (range: 29 – 44). 
An early birth was defined as gestational age of less than 37 weeks; 53 
(22.16%) mothers gave birth before 37 weeks of pregnancy. 
 
The majority of the children (52.55%) were born in Worcester at either the 
Eben Donges Hospital or the Maria Pieterse Maternity Obstetric Unit. The other 
study birthing sites were Ceres Hospital (18.24%), Robertson Hospital 
(17.25%) and Montagu Hospital (11.9696%). 
 
The majority of the study population (82.17%) were of coloured ethnicity. The 
remainder were of black ethnicity apart from one child who was of white 
ethnicity. To determine if there was an increased odds of tuberculosis disease 
in the coloured population, those of coloured ethnicity were compared to those 
of other ethnicity.  
 
The proportion of males in this cohort was slightly higher than females, with 
50.98% male. 
 
The mean birth weight was 2.78 kg (range: 1.08 – 5.55). Low birth weight was 
recorded in 27.25% of the study children, which is a higher figure than that 
estimated by WHO of approximately 15% of children born in sub-Saharan 
Africa with a birth weight less than 2.5 kg (WHO, 2008). 
 
4.3 Characteristics of the study population at time of TB 
investigation 
 
At the time of investigation for tuberculosis, the median age of the children 
was 18.13 months (range: 9.0 – 47.53). 
 
The mean haz was -1.18 (range: -5.05 – 2.44) and 27.45% of the study 
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The HIV status of 481 children was known, 2.91% of the children tested 
positive for HIV. 
 
182 (35.69%) of the study population had previously been treated for helminth 
infection. The treatment had been administered at the local health clinic. 
Reasons for helminth treatment included: 
• Mother had seen worms in the child’s stool 
• The child had complained of abdominal discomfort 
• Abdominal discomfort on examination 
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Table 13: Baseline characteristics in cases and controls 
 (primary analysis n=510) 
(Univariate logistic regression of an association between co-variables and tuberculosis) 
Variable Total (n=510) Cases (n=328) Controls (n=182) OR 95% CI 
Age at TB investigation (median & range) (mths) 18.13 (9.0–47.53) 18.02 (9.16–47.53) 18.48 (9.0–47.5) 0.99 0.97 – 1.01 
Gender (% male) 50.98 54.88 43.96 1.55 1.08 – 2.23 
Ethnicity (% coloured) 82.17 83.91 78.95 1.39 0.87 – 2.23 
Birth weight (mean & range) (kg) 2.78 (1.08–5.55) 2.75 (1.08–5.55) 2.83 (1.26–3.96) 0.77 0.55 – 1.09 
Low birth weight (% birth weight < 2.5 kg) 27.25 28.66 24.73 1.22 0.81 – 1.85 
Mother’s age at child’s birth (mean & range) (yrs) 25.71 (14.18–43.64) 25.65 (15.04–42.17) 25.83 (14.18–43.46) 0.99 0.97 – 1.03 
Gestation (median & range) (weeks) 39 (29–44) 39 (30-44) 39 (29–44) 0.98 0.91 – 1.06 
Early birth (% born before 37 weeks) 22.16 23.48 19.78 1.24 0.80 – 1.94 
Type of housing (% living in an informal dwelling) 9.41 9.45 9.34 1.01 0.54 – 1.89 
Type of community (% living on a farm) 23.53 23.78 23.08 1.04 0.68 – 1.60 
Number of occupants (median & range) 5 (1–20) 6 (1-20) 5 (1-13) 1.10 1.02 – 1.18 
haz (mean & range) -1.18 (-5.05–2.44) -1.35 (-5.05–2.34) -0.86 (-4.95–2.44) 0.78 0.68 – 0.89 
Birth site: (% born Worcester) 52.55 48.48 59.89 1.0  
Birth site: (% born Ceres) 18.24 20.12 14.84 1.68 1.01 – 2.80 
Birth site: (% born Robertson) 17.25 19.21 13.74 1.73 1.02 – 2.92 
Birth site: (% born Montagu) 11.96 12.20 11.54 1.31 0.73 – 2.34 
HIV status (%HIV exposed) 2.91 3.58 1.72 2.12 0.58 – 7.70 
Helminth treatment (% treated) 35.69 35.98 35.16 1.04 0.71 – 1.51 
IQR – interquartile range 
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Table 14: Baseline characteristics in cases and controls in the reduced sample 
 (primary analysis n=435) 
(Univariate logistic regression of an association between co-variables and tuberculosis) 
Variable Total (n=435) Cases (n=280) Controls (n=155) OR 95% CI 
Age at TB investigation (median & range) (mths) 17.80 (9.0–47.53) 17.55 (9.2-47.53) 18.40 (9.0-47.5) 0.98 0.96 – 1.01 
Gender (% male) 51.03 55.36 43.23 1.63 1.10 – 2.42 
Ethnicity (% coloured) 82.07 83.57 79.35 1.30 0.80 – 2.18 
Birth weight (mean & range) (kg) 2.81 (1.08–5.55) 2.78 (1.08-5.55) 2.87 (1.26-3.96) 0.70 0.48 – 1.03 
Low birth weight (% birth weight < 2.5 kg) 24.37 26.43 20.65 1.38 0.86 – 2.21 
Mother’s age at child’s birth (mean & range) (yrs) 25.54 (14.18–43.64) 25.47 (15.04-41.70) 25.65 (14.18-43.64) 0.99 0.97 – 1.03 
Gestation (median & range) (weeks) 39 (29–44) 39 (30-44) 39 (29-44) 0.94 0.87 – 1.03 
Early birth (% born before 37 weeks) 21.15 23.57 16.77 1.53 0.92 – 2.53 
Type of housing (% living in an informal dwelling) 8.97 8.57 9.68 0.88 0.44 – 1.72 
Type of community (% living on a farm) 23.91 25.36 21.29 1.26 0.79 – 2.01 
Number of occupants (median & range) 5 (1–20) 6 (1-20) 5 (1-13) 1.09 1.01 – 1.18 
haz (mean & range) -1.15 (-5.05–2.44) -1.33 (-5.05-2.34) -0.82 (-4.95-2.44) 0.77 0.66 – 0.89 
Birth site: (% born Worcester) 53.33 48.57 61.94 1.0  
Birth site: (% born Ceres) 17.93 19.64 14.84 1.69 0.97 – 2.93 
Birth site: (% born Robertson) 17.70 20.36 12.90 2.01 1.13 – 3.57 
Birth site: (% born Montagu) 11.03 11.43 10.32 1.41 0.73 – 2.72 
HIV status (% HIV exposed) 2.53 2.86 1.94 1.50 0.39 – 5.70 
Helminth treatment (% treated) 34.94 35.36 34.19 1.05 0.70 – 1.59 
IQR – interquartile range 
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The baseline characteristics of the reduced sample are similar to the baseline 
characteristics of the full sample used for the primary analysis, suggesting that 
reducing the sample to include only those children who have a complete set of 
data for the multivariate analysis will not influence the result, as shown in 
Tables 13 and 14. Both univariate analyses show that tuberculosis is associated 
with haz, gender, number of occupants sharing the same dwelling as the child 
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4.4 Primary analysis 
 
4.4.1 Potential confounding variables 
 
All co-variables were tested for potential confounding as described in the 
methods section. Number of occupants sharing the same dwelling as the child 
and haz are significantly related with tuberculosis in those not exposed to 
helminth treatment as shown in Table 15. Age and birth site are significantly 
related to exposure to helminth treatment as shown in Table 16. None of the 
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Table 15: Potential confounders 
 (primary analysis not exposed to helminth Rx) 
Co-variable Cases (n=181) Controls (n=102) OR 95% CI 
Age at TB investigation (median) (mths) 15.40 14.75 1.01 0.97 – 1.05 
Gender (% male) 52.49 45.10 1.34 0.83 – 2.19 
Ethnicity (% coloured) 82.874 80.39 1.18 0.63 – 2.20 
Birth weight (mean) (kg) 2.78 2.83 0.85 0.53 – 1.35 
Low birth weight (% birth weight < 2.5 kg) 25.41 23.53 1.11 0.63 – 1.95 
Mother’s age at child’s birth (mean) 25.51 25.56 1.00 0.96 – 1.04 
Gestation (median) (weeks) 39 39 0.95 0.86 – 1.05 
Early birth (% born before 37 weeks) 23.76 17.65 1.45 0.79 – 2.69 
Type of housing (% living in an informal dwelling) 9.39 10.78 0.86 0.39 – 1.91 
Type of community (% living on a farm) 25.97 23.53 1.14 0.65 – 2.01 
Number of occupants (median) 6 5 1.13 1.02 – 1.24 
haz (mean) -1.28 -0.89 0.83 0.70 – 0.99 
Birth site: (% born Worcester) 56.35 60.78 1.00  
Birth site: (% born Ceres) 14.36 12.75 1.46 0.74 – 2.88 
Birth site: (% born Robertson) 9.39 11.76 1.22 0.58 – 2.54 
Birth site: (% born Montagu) 9.52 11.86 0.86 0.39 – 1.92 
HIV status (% HIV exposed) 2.76 1.96 1.42 0.27 – 7.46 
IQR – interquartile range 
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Table 16: Potential confounders 
 (primary analysis association between helminth Rx and the co-variables) 
Co-variable Helminth Rx  
(n=152) 
No helminth Rx  
(n=283) 
OR 95% CI 
Age at TB investigation (median) (mths) 22.55 15.37 1.15 1.11 – 1.19 
Gender (% male) 53.29 49.82 1.15 0.77 – 1.71 
Ethnicity (% coloured) 82.24 81.98 1.02 0.61 – 1.70 
Birth weight (mean) (kg)  2.83 2.80 1.12 0.77 – 1.64 
Low birth weight (% birth weight < 2.5 kg) 23.68 24.73 0.94 0.60 – 1.50 
Mother’s age at child’s birth (mean) 25.56 25.53 1.00 0.97 – 1.03 
Gestation (median) (weeks) 39 39 1.05 0.97 – 1.15 
Early birth (% born before 37 weeks) 20.39 21.55 0.93 0.57 – 1.52 
Type of housing (% living in an informal dwelling) 7.24 9.89 0.71 0.34 – 1.47 
Type of community (% living on a farm) 21.71 25.09 0.84 0.52 – 1.32 
Number of occupants (median) 5 6 0.97 0.90 – 1.04 
haz (mean) -1.17 -1.14 0.99 0.86 – 1.13 
Birth site: (% born in Worcester) 44.74 57.96 1.00  
Birth site: (% born in Ceres) 17.76 18.02 1.28 0.74 – 2.20 
Birth site: (% born in Robertson) 25.00 13.78 2.35 1.39 – 3.99 
Birth site: (% born Montagu) 12.50 10.24 1.58 0.83 – 3.01 
HIV status (% HIV exposed) 2.63 2.47 1.07 0.31 – 3.07 
IQR – interquartile range 
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4.4.2 Univariate analysis 
 
Table 17: Association between helminth treatment and tuberculosis 
Model 1 (primary analysis n=510) 
Variable OR 95% CI 
Helminth treatment 1.04 0.71 – 1.51 
 
The univariate unadjusted analysis shows no association between tuberculosis 
and helminth treatment as shown in Table 17.  
 
4.4.3 Multivariate analysis 
 
The logistic regression analysis was performed on 435 children who had a full 
set of data for all variables included in this analysis.  
Observations that had missing data were excluded in the logistic regression 
analyses as shown in Tables 11 and 12. 
 
Table 18: Association between helminth treatment and tuberculosis 
Model 2 (primary analysis n=435) 
Variable OR 95% CI Akaike’s information 
criterion (AIC) 
Helminth treatment 1.05 0.70 – 1.59 570.55 
 
Model building proceeded by adding other risk factors to the model with 
helminth treatment, including the variables that proved to have a significant 
univariate association with tuberculosis disease as identified in Table 13. 
 
The model was increased by adding each of the co-variables separately. The 
best model was selected using the lowest Akaike’s information criterion (AIC) 
and the likelihood ratio test p value was used to determine if this was a 
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Table 19: Primary analysis 
Model 3 (adding each variable to the model of helminth Rx) 
Variable lrtest p-value AIC 
Age at investigation 0.11 569.94 
Gender 0.02 566.69 
Ethnicity 0.28 571.36 
Birth weight 0.06 569.13 
Low birth weight 0.17 570.69 
Mother’s age 0.78 572.47 
Gestation 0.18 570.71 
Early birth 0.09 569.70 
Housing 0.71 572.41 
Type of community 0.33 571.61 
Number of occupants 0.03 567.62 
haz <0.001 559.28 
HIV status 0.55 572.19 
Birth site 0.05 568.59 
 
Adding haz results in the most significant improvement to the model that only 
contained helminth treatment: AIC 559.28; lrtest p value < 0.001 as shown in 
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Table 20: Primary analysis adjusted for haz 
Model 4 (adding each variable to the model of helminth Rx and haz) 
Variable lrtest p-value AIC 
Age at investigation 0.23 559.86 
Gender 0.02 556.18 
Ethnicity 0.43 560.66 
Birth weight 0.85 561.24 
Low birth weight 0.88 561.26 
Mother’s age 0.56 560.94 
Gestation 0.41 560.61 
Early birth 0.23 559.76 
Housing 0.82 561.23 
Type of community 0.45 560.72 
Number of occupants 0.02 555.79 
HIV status 0.77 561.19 
Birth site 0.11 559.29 
 
Adding number of occupants results in the most significant improvement to the 
model that contained helminth treatment and haz: AIC 555.79; lrtest p value = 
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Table 21: Primary analysis adjusted for haz and number of occupants  
Model 5 (adding each variable to the model of helminth Rx, haz and number of 
occupants) 
Variable lrtest p-value AIC 
Age at investigation 0.23 556.31 
Gender 0.02 552.55 
Ethnicity 0.61 557.54 
Birth weight 0.96 557.79 
Low birth weight 0.97 557.97 
Mother’s age 0.61 557.54 
Gestation 0.50 557.35 
Early birth 0.27 556.60 
Housing 0.01 557.78 
Type of community 0.92 556.88 
HIV status 0.70 557.64 
Birth site 0.15 556.42 
 
Adding gender results in the most significant improvement to the model that 
contains helminth treatment, haz and number of occupants: AIC 552.55; lrtest 
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Table 22: Primary analysis adjusted for haz, number of occupants and 
gender 
Model 6 (adding each variable to the model of helminth treatment, haz, 
number of occupants and gender) 
Variable lrtest p-value AIC 
Age at investigation 0.23 553.09 
Ethnicity 0.67 554.37 
Birth weight 0.73 554.44 
Low birth weight 0.86 554.52 
Mother’s age 0.50 554.10 
Gestation 0.45 553.98 
Early birth 0.29 553.42 
Housing 0.99 554.55 
Type of community 0.38 553.78 
HIV status 0.66 554.35 
Birth site 0.10 552.36 
 
Adding birth site is an improvement on the model that contains helminth 
treatment, haz and number of occupants and gender: AIC 552.36; lrtest p 
value = 0.10 as shown in Table 22. Although this is not a statistically significant 
result at the 95% level of confidence it was felt that it should be included in 
the final model as it had a positive association with tuberculosis in the baseline 
univariate analysis as shown in Table 13. 
 
There is no further improvement to the model by adding additional variables. 
The best model to examine a relationship between tuberculosis and helminth 
treatment is a model that includes helminth treatment, haz, number of 
occupants living in the same dwelling as the child, gender and birth site as 
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Table 23: Primary analysis final model adjusted for haz, number of 
occupants, gender and birth site  
Model 7 (AIC 552.36) 
Variable OR 95% CI 
haz 0.78 0.67 – 0.91 
Number of occupants 1.10 1.01 – 1.19 
Gender 1.67 1.11 – 2.51 
Birth site Worcester 1.0  
Birth site Ceres 1.56 0.88 – 2.77 
Birth site Robertson 1.94 1.07 – 3.51 
Birth site Montagu 1.38 0.71 – 2.71 
Helminth treatment 0.98 0.64 – 1.51 
 
The validity of the model was examined using a plot of residuals versus the 
linear component of the model as shown in Appendix A figure 3. Pearson chi-
square p value of 0.3331 indicates a reasonably good fit, p > 0.05. 
 
After adjusting for the effect of haz, number of occupants living in the same 
dwelling as the child, gender and birth site, there was still no evidence of an 
association between helminth treatment and tuberculosis disease. 
 
Although the OR changed from an unadjusted OR of 1.05 to 0.98 this is only a 
difference of 6.6% and the OR is very close to 1 with a 95% CI that includes 1, 
indicating that there is no relationship between tuberculosis and helminth 
treatment. 
 
The observed relative difference of 5% is much smaller than the hypothesized 
50% relative effect on which the initial power calculations were done at the 
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for helminth infection in this analysis of 328 cases of tuberculosis and 182 
controls of not TB, the study is only 3% powered to prove this reduced relative 
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Table 24: Power of the study  
(primary univariate analysis n=510)  
Proportion of cases treated for 
helminth infection 
Proportion of controls treated 
for helminth infection 
OR 95% CI Power 
35.98% 35.16% 1.05 0.70 – 1.59 3% 
 
Table 25: Power of the study 
 (primary multivariate analysis n=435)  
Proportion of cases treated for 
helminth infection 
Proportion of controls treated 
for helminth infection 
OR 95% CI Power 
35.36% 34.19% 1.05 0.70 – 1.60 3% 
 
This study showed a much smaller difference in proportion of cases and controls exposed to helminth treatment than used in the 
original sample size calculations. Thus, the study ended up being under-powered. Table 24 shows that for the univariate analysis of 
the association between helminth treatment and tuberculosis, there was only 3% power to prove the observed effect as measured 
by an OR of 1.05 to be statistically significant at the 5% level. This power remains at 3% for the reduced sample used in the 
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Once the best model had been selected using 435 children who had a full set 
of data for all variables included in this sub-set, as shown in Table 23, the 
multivariate analysis was repeated using as many observations as possible as 
shown in Table 26. 
 
Table 26: Primary analysis adjusted for haz, number of occupants, 
gender and birth site (n=493) 
Model 8 (AIC 552.36) 
Variable OR 95% CI 
haz 0.79 0.69 – 0.91 
Number of occupants 1.11 1.02 – 1.19 
Gender 1.56 1.07 – 2.29 
Birth site Worcester 1.0  
Birth site Ceres 1.38 0.81 – 2.34 
Birth site Robertson 1.68 0.97 – 2.92 
Birth site Montagu 1.42 0.77 – 2.64 
Helminth treatment 1.03 0.69 – 1.53 
 
The result is similar to the model that analysed 435 children. There is no 
relationship between helminth treatment and tuberculosis. However birth site is 
no longer significant at the 95% level of confidence. 
 
The validity of the model was examined using a plot of residuals versus the 
linear component of the model as shown in Appendix A figure 4. Pearson chi-
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4.5 Secondary analysis  
(Including those classified as “unlikely TB” with the control group). 
 
Baseline characteristics of the secondary analysis are similar to the baseline 
characteristics of the children included in the primary analysis as shown in 
Table 26. Both univariate analyses show that tuberculosis is associated with 
haz, gender and number of occupants sharing the same dwelling as the child. 
However birth site is not statistically significantly associated with tuberculosis in 
the secondary analysis as it was in the primary analysis and HIV status now 
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Table 27: Baseline characteristics in cases and controls 
 (secondary analysis n=847) 
(Univariate logistic regression of an association between co-variable and tuberculosis n= 847) 
Variable Total (n=847) Cases (n=328) Controls (n=519) OR 95% CI 
Age at TB investigation (median & range) (mths) 18.37 (9–47.53) 18.02 (9.17-47.53) 18.9 (9.0-47.50) 0.99 0.97 – 1.01 
Gender (% male) 50.89 54.88 45.12 1.2 0.98 – 1.71 
Ethnicity (% coloured) 84.03 83.91 84.11 0.98 0.67 – 1.45 
Birth weight (mean & range) (kg) 2.79 (1.08–5.55) 2.75 (1.08-5.55) 2.82 (1.26-4.44) 0.79 0.61 – 1.03 
Low birth weight (% birth weight < 2.5 kg) 27.27 28.66 26.4 1.12 0.82 – 1.53 
Mother’s age (mean & range) 25.85 (14.18–46.56) 25.65 (15.04-42.17) 25.98 (14.18-46.56) 0.99 0.97 – 1.01 
Gestation (median & range) (weeks) 39 (29–44) 39 (30-44) 39 (29-44) 0.99 0.94 – 1.05 
Early birth (% born before 37 weeks) 21.96 23.44 21.00 1.15 0.83 – 1.16 
Type of housing (% living in an informal dwelling) 10.39 9.45 10.98 0.85 0.53 – 1.34 
Type of community (% living on a farm) 24.32 23.78 24.66 0.95 0.69 – 1.32 
Number of occupants (median & range) 5 (1–20) 6 (1-20) 5 (1-14) 1.05 1.00 – 1.12 
HAZ (mean & range) -1.08 (-5.05–5.07) -1.45 (-5.05-2.34) -0.94 (-4.95-5.07) 0.80 0.72 – 0.88 
Birth site: (% born Worcester) 51.59 48.48 53.56 0.82 0.62 – 1.08 
Birth site: (% born Ceres) 19.60 20.12 19.27 1.06 0.75 – 1.49 
Birth site: (% born Robertson) 17.24 19.21 15.99 1.25 0.87 – 1.79 
Birth site: (% born Montagu) 11.57 12.20 11.18 1.10 0.72 – 1.70 
Helminth treatment (% treated) 38.61 35.98 40.27 0.83 0.63 – 1.11 
HIV status (% infected) 2.13 3.58 1.22 3.01 1.10 – 8.22 
IQR – interquartile range 
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All co-variables were tested for potential confounding using the method 
described earlier. Number of occupants sharing the same dwelling as the child 
and haz are significantly related with tuberculosis in those not exposed to 
helminth treatment as shown in Table 28. Age and birth site are significantly 
related to exposure to helminth treatment as shown in Table 29. None of the 
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Table 28: Potential confounders 
 (secondary analysis not exposed to helminth Rx) 
Variable Cases (n=210) Controls (n=310) OR 95% CI 
Age at TB investigation (median) (mths) 15.72 14.78 1.01 0.98 – 1.04 
Gender (% male) 51.90 46.77 1.23 0.87 – 1.74 
Ethnicity (% coloured) 84.23 83.45 1.06 0.65 – 1.73 
Birth weight (mean) (kg) 2.75 2.81 0.80 0.57 – 1.12 
Low birth weight (% birth weight < 2.5 kg) 28.10 27.10 1.05 0.71 – 1.56 
Mother’s age (mean) 25.68 25.64 1.00 0.97 – 1.03 
Gestation (median) (weeks) 39 38 0.99 0.92 – 1.06 
Early birth (% born before 37 weeks) 24.29 20.97 1.21 0.80 – 1.84 
Type of housing (% living in an informal dwelling) 9.52 11.29 0.83 0.46 – 1.48 
Type of community (% living on a farm) 25.71 26.45 0.96 0.65 – 1.43 
Number of occupants (median) 6 5 1.08 1.01 – 1.16 
haz (mean) -1.30 -0.93 0.84 0.74 – 0.95 
Birth site: (% born Worcester) 55.72 55.51 1.00  
Birth site: (% born Ceres) 20.95 22.26 0.94 0.60 – 1.46 
Birth site: (% born Robertson) 13.81 11.29 1.22 0.71 – 2.10 
Birth site: (% born Montagu) 9.52 10.97 0.86 0.47 – 1.58 
HIV status (% infected) 3.00 0.67 4.56 0.91 – 22.83 
haz (mean) -1.30 -0.93 0.84 0.74 – 0.95 
IQR – interquartile range 
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Table 29: Potential confounders 
 (secondary analysis association between helminth Rx and the co-variables) 
Variable Helminth Rx 
(n=327) 





Age at TB investigation (median) (months) 22.90 15.36 1.15 1.12 – 1.18 
Gender (% male) 54.13 48.85 1.24 0.94 – 1.63 
Ethnicity (% coloured) 88.44 83.77 1.05 0.71 – 1.55 
Birth weight (mean) (kg) 2.81 2.78 1.08 0.83 – 1.41 
Low birth weight (% birth weight < 2.5 kg) 26.91 27.50 0.97 0.71 – 1.32 
Mother’s age (mean) 26.16 25.66 1.01 0.99 – 1.03 
Gestation (median) (weeks) 39 38 1.05 0.99 – 1.11 
Early birth (% born before 37 weeks) 21.41 22.31 0.95 0.68 – 1.33 
Type of housing (% living in an informal dwelling) 10.09 10.58 0.95 0.60 – 1.50 
Type of community (% living on a farm) 21.41 26.15 0.78 0.55 – 1.07 
Number of people living in the same dwelling (median) 6 5 0.98 0.92 – 1.03 
haz (mean) -1.09 -1.07 0.99 0.90 – 1.10 
Birth site: (% born Worcester) 45.25 55.58 1.00  
Birth site: (% born Ceres) 16.21 21.73 0.92 0.63 – 1.34 
Birth site: (% born Robertson) 25.08 12.31 2.50 1.71 – 3.67 
Birth site: (% born Montagu) 13.46 10.38 1.59 1.02 – 2.48 
HIV status (% infected) 2.98 1.61 1.88 0.72 – 4.92 
IQR – interquartile range 
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4.5.1 Univariate analysis  
 
Table 30: Association between helminth treatment and tuberculosis 
Model 9 (secondary analysis n=847) 
Variable OR 95% CI 
Helminth treatment 0.83 0.63 – 1.11 
 
The univariate unadjusted analysis shows a 17% relative reduction in the odds 
of tuberculosis. However, this result is not statistically significant at the 5% 
level of significance as shown in Table 30. 
 
4.5.2 Multivariate analysis 
 
The logistic regression analysis was performed on 724 children who had a full 
set of data for all variables included in this sub-set.  
 
Table 31: Association between helminth treatment and tuberculosis 
Model 10 (secondary analysis n=724) 
Variable OR 95% CI AIC 
Helminth treatment 0.83 0.61 – 1.14 968.86 
 
Model building proceeded by adding other risk factors to the model with 
helminth treatment, including variables that proved to have a significant 
univariate association with tuberculosis disease, including those identified in 
Table 27.  
The model was increased by adding each of the co-variables separately. The 
best model was selected by using the lowest Akaike’s information criterion 
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Table 32: secondary analysis 
Model 11 (adding each variable to the model of helminth Rx) 
Variable lrtest p-value AIC 
Age at investigation 0.08 967.81 
Gender 0.05 967.07 
Ethnicity 0.77 970.78 
Birth weight 0.16 968.92 
Low birth weight 0.67 970.68 
Mother’s age 0.45 970.28 
Gestation 0.50 970.41 
Early birth 0.12 968.40 
Housing 0.23 969.45 
Type of community 0.22 970.64 
Number of occupants 0.03 966.32 
haz <0.001 952.85 
HIV status 0.15 968.75 
Birth site 0.20 970.23 
 
Adding haz results in the most significant improvement to the model that only 
contained helminth treatment: AIC 952.85; lrtest p value < 0.001 as shown in 
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Table 33: Secondary analysis adjusted for haz 
Model 12 (adding each variable to the model of helminth Rx and haz) 
Variable lrtest p-value AIC 
Age at investigation 0.17 952.97 
Gender 0.07 951.46 
Ethnicity 0.45 954.27 
Birth weight 0.51 954.41 
Low birth weight 0.23 953.41 
Mother’s age 0.18 953.05 
Gestation 0.93 954.84 
Early birth 0.95 953.89 
Housing 0.19 953.11 
Type of community 0.94 954.84 
Number of occupants 0.02 949.27 
HIV status 0.26 953.57 
Birth site 0.28 955.00 
 
Adding number of occupants results in the most significant improvement to the 
model that contained helminth treatment and haz: AIC 949.27; lrtest p value = 
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Table 34: Secondary analysis adjusted for haz and number of 
occupants  
Model 13 (adding each variable to the model of helminth Rx, haz and number 
of occupants) 
Variable lrtest p-value AIC 
Age at investigation 0.17 949.37 
Gender 0.07 947.94 
Ethnicity 0.99 950.27 
Birth weight 0.47 950.74 
Low birth weight 0.21 949.71 
Mother’s age 0.23 949.80 
Gestation 0.85 951.23 
Early birth 0.40 950.56 
Housing 0.33 950.30 
Type of community 0.75 951.16 
HIV status 0.21 949.69 
Birth site 0.33 951.85 
 
Adding gender results in the most significant improvement to the model that 
contains helminth treatment, haz and number of occupants: AIC 947.94; lrtest 
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Table 35: Primary analysis adjusted for haz, number of occupants and 
gender 
Model 15 (adding each variable to the model of helminth treatment, haz, 
number of occupants and gender) 
Variable lrtest p-value AIC 
Age at investigation 0.19 948.26 
Ethnicity 0.31 948.91 
Birth weight 0.65 949.74 
Low birth weight 0.30 948.86 
Mother’s age 0.16 947.99 
Gestation 0.89 949.92 
Early birth 0.40 949.23 
Housing 0.29 948.83 
Type of community 0.82 949.89 
HIV status 0.22 948.42 
Birth site 0.33 950.53 
 
There is no further improvement to the model by adding additional variables. 
The best model to examine a relationship between tuberculosis and helminth 
treatment is a model that includes helminth treatment, haz, number of 
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Table 36: Secondary analysis adjusted for haz, number of occupants 
and gender 
Model 16 (AIC 947.94) 
Variable OR 95% CI 
haz 0.79 0.71 – 0.88 
Number of occupants 1.08 1.01 – 1.44 
Gender 1.33 0.98 – 1.81 
Helminth treatment 0.82 0.60 – 1.13 
 
After adjusting for the effect of haz, gender (not significant at the 5% level of 
significance) and number of occupants living in the same dwelling as the child, 
the relationship between helminth treatment and tuberculosis disease remains 
unchanged as shown in Table 36. 
 
The validity of the model was examined using a plot of residuals versus the 
linear component of the model as shown in Appendix A figure 5. Pearson chi-
square p value of 0.4347 indicates a reasonably good fit, P > 0.05. 
 
 
Given the proportion of cases and controls treated for helminth infection in this 
analysis of 328 cases of tuberculosis and 519 controls of unlikely or not TB, the 
study is only 22% powered to prove this reduced relative difference significant 
at the 5% level of significance, in the unadjusted univariate analysis. This 
power reduces to 19% in the adjusted multivariate analysis as shown in Tables 
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Table 37: Power of the study 
 (secondary analysis n=847)  
Proportion of cases treated for 
helminth infection 
Proportion of controls treated for 
helminth infection 
OR 95% CI Power 
35.98 40.27 0.83 0.63 – 1.11 22% 
 
Table 38: Power of the study 
 (secondary analysis n=724)  
Proportion of cases treated for 
helminth infection 
Proportion of controls treated for 
helminth infection 
OR 95% CI Power 
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Once the best model had been selected using the 724 children who had a full 
set of data for all variables included in this sub-set as shown in Table 36, the 
multivariate analysis was repeated using as many observations as possible as 
shown in Table 39. 
 
Table 39: Secondary analysis adjusted for haz, number of occupants 
and gender (n=822) 
Model 17  
Variable OR 95% CI 
haz 0.79 0.72 – 0.88 
Number of occupants 1.07 1.01 – 1.13 
Gender 1.30 0.97 – 1.72 
Helminth treatment 0.85 0.63 – 1.14 
 
The result is similar to the model that analysed 724 children. There is no 
relationship between helminth treatment and tuberculosis, the relative 
reduction in tuberculosis odds is 15% but this was not a statistically significant 
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5. DISCUSSION  
 
The principal findings of the primary analysis of this study do not demonstrate 
that children who have been treated for helminth infection and live in a 
community with a high tuberculosis burden are better protected against 
tuberculosis disease than those not treated for helminth infection. While the 
secondary analysis which included those classified as unlikely tuberculosis in 
the control group showed a decrease in tuberculosis odds of 17% in the 
univariate analysis and 15% in the adjusted multivariate analysis, this result 
was not statistically significant at the 95% level of significance. 
 
One of the strengths of this study was that all the children included in the 
analysis were investigated for tuberculosis in a hospital ward that had been 
specifically equipped to perform tests used in the diagnosis of tuberculosis. The 
procedures and tests were performed by study staff who had been trained in 
protocol and standardised methods. This standardised method of performing 
the necessary tests would have minimised the diagnostic measurement error. 
 
As this is a case control study, careful attention was paid to the selection of the 
control groups. In the primary analysis the control group comprised children 
who were completely asymptomatic. These children were selected for 
investigation of tuberculosis as they had been exposed to an adult case of 
tuberculosis. It was felt that although they could have been less healthy than, 
and therefore not fully representative of, the underlying population of this age 
group, it was unlikely that this would have changed the results of the study as 
the OR was very close to 1.  
 
The secondary analysis was performed to establish if the result of the primary 
analysis held true when those classified as “unlikely TB” were included in the 
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As both helminth infection and tuberculosis are strongly associated with loss of 
weight and malnutrition, multivariate analysis which adjusted for these 
variables was used.  
 
Factors that could have influenced these results include temporality; it was not 
known when the child was treated for helminth infection. This could have been 
some months before the tuberculosis investigation and thus the child had the 
opportunity to become re-infected with helminths. In addition, this study was 
not equipped to measure helminth infection prevalence directly; the exposure 
variable that was analysed was only of a history of helminth treatment. 
 
One of the difficulties in trying to establish an association between tuberculosis 
and helminth infection is the fact that they are both chronic diseases, therefore 
it cannot be established with certainty whether helminth infection preceded 
tuberculosis or if chronic tuberculosis might have led to an increased risk of 
helminth infection. It is possible that the tuberculosis disease process might 
have started before helminth treatment and might have been undetected.  
 
It is also not known if the helminth treatment had been effective. It is possible 
that there were children who had been given helminth treatment but were still 
infected with helminths and thus remained at greater risk of tuberculosis than 
others effectively treated. 
 
To validate the accuracy of the mother’s recall of previous treatment for 
helminth infection, a 10% sample of CRFs were compared to the child’s RTHC 
where a record of helminth treatment was recorded by staff at the local health 
facility. No discrepancies in the 10% sample check was found. 
 
 It is unlikely that the mother of the child would have accessed helminth 
treatment from a source other than the local health centre, but it is possible 
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The results of our study differed from other reported research in that two 
previous case control studies (Tristao-Sa et al. 2002; Elias et al. 2006) found 
strong associations between helminth infection (as established by examination 
of stools) and tuberculosis. However, the primary objectives of these studies 
were to study the prevalence of helminth infection in relation to tuberculosis 
disease. In neither of these two studies is it known if any participants had 
previously been treated for helminth infection. It is possible that a larger 
proportion of the controls had been treated for helminth infection and this 
could have been a factor that protected them from tuberculosis. 
 
The populations that were previously studied were also different from the 
population that was investigated in this study. Both previous case control 
studies were conducted in adults and older children with an age range of 10–
80 years. In contrast, the primary objective of this case control study was to 
determine if children who had been treated for helminth infection had a 
reduced risk of tuberculosis in the first five years of life. The focus of this 
research was thus not on the prevalence of helminths but rather the effect of 
helminth treatment on tuberculosis risk in young children. 
 
In addition to the above findings, this study found an association between 
tuberculosis and malnutrition, gender and birth site. 
 
A haz below -2 describes stunting which implies long term malnutrition and 
poor health (WHO, 2007). A total of 27.25% of the study population presented 
with a haz less than -2, indicating a high proportion of chronically malnourished 
children. There was a large and statistically significant difference in the 
proportion of children with a haz <-2 between the cases and controls, 33.21% 
and 13.55% respectively (OR 3.17; 95% CI 1.88 – 5.35). Children who present 
with a haz of <-2 are three times more likely to develop tuberculosis than 
children who present with a haz of >-2 indicating a strong relationship between 
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The association between malnutrition and tuberculosis has been explored by 
many researchers and these results support previous findings (Elias et al. 
2001; Campbell et al. 2006; Alderman et al. 2006). 
 
This analysis also showed that children born at the Ceres Hospital or Robertson 
Hospital were more likely to be diagnosed with tuberculosis than those born in 
Worcester at either the Eden Donges Hospital or Maria Pieterse Maternity 
Health Unit. The reason for this difference is not known. 
 
This study found a statistically significant difference between the odds of 
tuberculosis in males and females. Male children were 1.5 times more likely to 
be diagnosed with tuberculosis than female children. Differences in incidence of 
tuberculosis by gender have been noted in previous adult and adolescent 
research, with results indicating that males are more at risk of tuberculosis 
than females (Holmes et al. 1998; Nissapatorn et al. 2006). However this 
difference has not been noted in children. In a review of gender differences in 
the epidemiology of tuberculosis, Holmes et al. (1998) found that differences in 
incidence between genders became apparent only after adolescence. They 
concluded that this gender differential after adolescence was probably due to 
under reporting of female cases of tuberculosis in developing regions. 
 
Data reported from the National Tuberculosis Centre in Malaysia from January, 
2001, to December, 2002, found that 68% of the tuberculosis cases reported 
were male. This report suggested that these differences in gender were 
probably due to increasing patterns of non-adherence to tuberculosis treatment 
in males and poor socio-economic conditions (Nissapatom et al. 2006).  
 
These gender differences in adults with tuberculosis are confirmed in a report 
by the WHO (2002); However, they state that in most settings the higher 
incidence of tuberculosis in males only begins to appear between the ages of 
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6. CONCLUSION 
 
The benefits of deworming young children have been well documented: 
reducing the number of young children infected with helminths will result in 
improved physical growth and cognition as well as in improved development of 
children (Alderman et al. 2006). 
 
The South African Department of Health policy and guidelines for regular 
treatment of school-going children for soil transmitted helminth infection state 
that regular deworming of children aged two to five years is included in the 
Integrated Management of Childhood Illness (IMCI) case management 
guidelines and that every child between the ages of one and five years should 
receive regular six-monthly deworming. 
 
Although this study did not show any effect of helminth treatment on the risk 
of tuberculosis in young children, the benefit of deworming on weight gain is 
sufficient justification for regular deworming. 
 
The primary analysis of this observational study does not support the 
hypothesis that helminth treatment reduces the risk of tuberculosis disease in 
young children in a high-risk tuberculosis population. None of the variables met 
a priori for potential confounding. The result was thus unchanged when 
adjusted for the effect of haz, number of occupants sharing the same dwelling 
as the child, gender and birth site. 
 
Although the secondary analysis showed a 17% reduction in tuberculosis odds, 
this was not a statistically significant result. The result was also essentially 
unchanged when adjusted for the effect of haz, number of occupants sharing 










  76 
7. REFERENCES 
 
Adams VJ, Markus MB, Adams JF, Jordaan E, Curtis B, Dhansay MA, Obihara 
CC, Fincham JE. 2005. Paradoxical helminthiasis and giadiasis in Cape Town, 
South Africa: Epidemiology and control. African Health Sciences, 5(3): 276-280. 
 
Alderman H, Konde-Lule J, Sebuliba I, Bundy D, Hall A. 2006 Effect on weight 
gain of routinely giving albendazole to preschool children during child health 
days in Uganda: cluster randomised controlled trial.
 
 British Medical Journal, 
333(7559): 122-124.  
Bentwich Z, Kalinkovich A, Weisman Z, Borkow G, Beyers N, Beyers A. 1999. 
Can eradication of helminthic infections change the face of AIDS and 
tuberculosis? Immunology Today, 20(11): 485-487. 
 
Bergman N. 1995. A ‘treatment score’ for primary and pulmonary tuberculosis. 
The Central African Journal of Medicine, 41: 1-6. 
 
Borkow G, Leng Q, Weisman Z, Stein M, Galai N, Kalinkovich A, Bentwich Z. 
2000. Chronic immune activation associated with intestinal helminth infection 
results in impaired signal transduction and anergy. The Journal of Clinical 
Investigation, 106(8): 1053-1060. 
 
Brown M, Mawa P, Kaleebu P, Elliot A. 2006. Helminths and HIV infection: 
epidemiological observations on immunological hypotheses. Parasite 
immunology. [Online]. Available: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid
=17042933 [01 July 2009] 
 











  77 
Bundy D, Sher A, Micheal E. 2000. Good Worms or Bad Worms: Do Worm 
Infestations Affect the Epidemiological Patterns of Other Diseases? Parasitology 
Today, 16(7): 273-274. 
 
Campbell I, Bah-Sow O. 2006. Pulmonary tuberculosis: diagnosis and 
treatment. British Medical Journal. [Online]. Available: 
http://bmj.com/cgi/content/full/332/7551/1194
 
 [20 May 2007] 
Editorial Anon. The Lancet. Thinking beyond deworming. 2004, The Lancet. 
364(9450): 1993-1994   
 
Elias D, Wolday D, Akuffo H, Petros B, Bronners U, Britton S. 2001. Effect of 
deworming on human T cell responses to mycobacterial antigens in helminth-
exposed individuals before and after bacille Calmette-Guérin (BCG) vaccination. 
Clinical and experimental Immunology, 123: 219-225. 
 
Elias D, Mengistu G, Akuffo H, Britton S. 2006. Are intestinal helminths risk 
factors for developing active tuberculosis? Tropical Medicine and International 
Health, 11(4): 551-558. 
 
Elliot A, Kizza M, Quigley M, Ndibazza J, Nampijja M, Muhangi L, Morison L, 
Namujja P, Muwanga M, Kabatereine N, Whitworth A. 2007. The impact of 
helminths on the response to immunisation and on the incidence of infection 
and disease in childhood in Uganda: design of a randomised, double-blind, 
placebo-controlled, factorial trial of deworming interventions delivered in 
pregnancy and early childhood. Clinical Trials, 4: 42-57. 
 
Fincham J. Helminths, HIV/AIDS and tuberculosis. 2001. Science in Africa. 
[Online]. Available: 












  78 
Grosset J. 2003. Mycobacterium tuberculosis in the Extracellular Compartment: 
an Underestimated Adversary. Antimicrobial Agents and Chemotherapy, 47(3): 
833-836. 
 
Hanekom W,  Abel B, Scribe J. 2007. Immunology protection against 
tuberculosis. South African Medical Journal, 97(10): 793-977. 
 
Hawkridge A, Hatherill M, Little F, Goetz MA, Barker L, Mahommed H, Sadoff J, 
Hanekom W, Geiter L, Hussey G. Efficacy of percutaneous versus intradermal 
BCG in the prevention of tuberculosis in South African infants: randomised trial. 





Holmes C, Hausler H, Nunn P. A review of sex differences in the epidemiology 
of tuberculosis. 1998. International Journal of Tuberculosis and Lung Disease, 
2(2): 96-104. 
 
Lloyd M, Lederman S. 2002. Anthropometry and moderate malnutrition in 
preschool children. Indian Journal of Paediatrics, 69(10): 771-774. 
 
Marais B, Gie R, Hesseling A, Schaaf S, Lombard Cl, Enarson D, Beyers N. A 
Refined Symptom-Based Approach to Diagnose Pulmonary Tuberculosis in 
Children. 2006. Pediatrics. [Online]. Available: 
http://pediatrics.aappublications.org/cgi/content/full/118/5/e1350
Nicol M, Davies MA, Wood K, Hatherill M, Workman L, Hawkridge T, Hanslo M, 
Eley B, Wilkinson R, Hanekom W, Beatty D, Hussey G. 2008.  A comparison of 
T-Spot.TB and tuberculin skin test for the evaluation of young children at high 
risk for tuberculosis in a community setting. 2009. Pediatrics. [Online]. 
















[26 February 2009] 
Nissapatorn V, Kuppusamy I, Sim B, Kia Fatt Q, Khairul Anuar A. 
Pulmonary tuberculosis in a hospital setting: Gender differences. 2006. Journal 
of the Royal Institute of Public Health. 120(5): 441-443. 
 
Rook A, Dheda K, Zumla A. 2006. Immune systems in developed and 
developing countries; implications for the design of vaccines that will work 
where BCG does not. Tuberculosis.  
[Online]. Available: http://inti.elsevierhealth.com/journals/tube
 
 [26 March 
2008] 
Schaaf S, Marais B, Whitelaw A, Hesseling A, Eley B, Hussey G, Donald P. 
2007. Culture-confirmed childhood tuberculosis in Cape Town, South Africa: a 
review of 596 cases. BMC Infectious Diseases. [Online]. Available: 
http://www.biomedcentral.com/1471/7/140
 
 [26 May 2008] 
Smuts CM, Faber M, Fincham JE, Oelofse A, Benade AJS. 2004. Integrated 
Nutritional Programme (INP). Baseline Survey in KwaZulu-Natal and the 
Eastern Cape. Part 1. Medical Research and Health Systems Trust collaborative 
study. Community based survey. South African Medical Research Council, Cape 
Town.  
 
South African National Department of Health. Regular treatment of school-
going children for soil-transmitted helminth infections and bilharzia: Policy and 














  80 
Tristao-Sa R, Ribeiro-Rodrigues R, Johnson L, Pereira F, Dietze R. 2002. 
Intestinal nematodes and pulmonary tuberculosis: Revista de Sociedade 
Brasileira de Medicina Tropical, 35(5)533: 535. 
 
Walls T, Shingadia D. 2004. Global epidemiology of paediatric tuberculosis. 





46072fc31f37b9fd55b [24 May 2008] 
 
Waterlow JC. 1972. Classification and definition of protein-calorie malnutrition. 
BMJ, 3(5826): 566-569. 
 




[13 February 2008] 
WHO. 2002. Gender and Tuberculosis.[Online]. Available. 
http://www.who.int/gender/documents/en/TB.factsheet.pdf
 
 [03 August 2009] 





WHO. 2007. Standard deviation of anthropometric Z-scores as a data quality 
assessment tool using the 2006 WHO growth standards: a cross country 
analysis. [Online]. Available: 
http://www.who.int/bulletin/volumes/85/6/06-034421/en/
 










  81 















  82 
 
AP P E NDIX A:  MODE L  C HE C K ING  G R AP HS  
 
Figure 3: Plot of residuals versus the linear component of the model 
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Figure 4: Plot of residuals versus the linear component of the model. 
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Figure 5: Plot of residuals versus the linear component of the model. 
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